{
  "1": [
    [
      ""
    ]
  ],
  "ipo_details": [
    [
      "IPO Date",
      "May 27, 2025toMay 29, 2025"
    ],
    [
      "Listing Date",
      "[.]"
    ],
    [
      "Face Value",
      "₹10per share"
    ],
    [
      "Issue Price Band",
      "₹128 to ₹135 per share"
    ],
    [
      "Lot Size",
      "1,000 Shares"
    ],
    [
      "Total Issue Size",
      "27,90,000shares(aggregating up to ₹37.67Cr)"
    ],
    [
      "Fresh Issue",
      "27,90,000shares(aggregating up to ₹37.67Cr)"
    ],
    [
      "Issue Type",
      "BookbuildingIPO"
    ],
    [
      "Listing At",
      "BSE SME"
    ],
    [
      "Share Holding Pre Issue",
      "77,21,000shares"
    ],
    [
      "Share Holding Post Issue",
      "1,05,11,000shares"
    ],
    [
      "Market Maker Portion",
      "1,44,000shares"
    ]
  ],
  "reservation": [
    {
      "Investor Category": "QIB Shares Offered",
      "Shares Offered": "Not more than 50% of the Net Issue"
    },
    {
      "Investor Category": "Retail Shares Offered",
      "Shares Offered": "Not less than 35% of the Net Issue"
    },
    {
      "Investor Category": "NII (HNI) Shares Offered",
      "Shares Offered": "Not less than 15% of the Net Issue"
    }
  ],
  "timeline": [
    [
      "IPO Open Date",
      "Tue, May 27, 2025"
    ],
    [
      "IPO Close Date",
      "Thu, May 29, 2025"
    ],
    [
      "Tentative Allotment",
      "Fri, May 30, 2025"
    ],
    [
      "Initiation of Refunds",
      "Mon, Jun 2, 2025"
    ],
    [
      "Credit of Shares to Demat",
      "Mon, Jun 2, 2025"
    ],
    [
      "Tentative Listing Date",
      "Tue, Jun 3, 2025"
    ],
    [
      "Cut-off time for UPI mandate confirmation",
      "5 PM onMay 29, 2025"
    ]
  ],
  "lots": [
    {
      "Application": "Retail (Min)",
      "Lots": "1",
      "Shares": "1000",
      "Amount": "₹1,35,000"
    },
    {
      "Application": "Retail (Max)",
      "Lots": "1",
      "Shares": "1000",
      "Amount": "₹1,35,000"
    },
    {
      "Application": "HNI(Min)",
      "Lots": "2",
      "Shares": "2,000",
      "Amount": "₹2,70,000"
    },
    {
      "Application": "Lot Size Calculator",
      "Lots": "",
      "Shares": "",
      "Amount": ""
    }
  ],
  "promoters_holdings": [
    [
      "Share Holding Pre Issue",
      "98.42%"
    ],
    [
      "Share Holding Post Issue",
      ""
    ]
  ],
  "company_financials": [
    [
      "Period Ended",
      "31 Dec 2024",
      "31 Mar 2024",
      "31 Mar 2023",
      "31 Mar 2022"
    ],
    [
      "Assets",
      "96.52",
      "80.89",
      "64.28",
      "52.91"
    ],
    [
      "Revenue",
      "69.69",
      "80.29",
      "67.26",
      "30.17"
    ],
    [
      "Profit After Tax",
      "4.10",
      "3.81",
      "0.67",
      "0.25"
    ],
    [
      "Net Worth",
      "17.28",
      "11.97",
      "8.16",
      "7.49"
    ],
    [
      "Reserves and Surplus",
      "9.56",
      "4.37",
      "4.16",
      "3.49"
    ],
    [
      "Total Borrowing",
      "49.48",
      "42.40",
      "35.99",
      "29.52"
    ],
    [
      "Amount in ₹ Crore"
    ]
  ],
  "KPI": [
    {
      "KPI": "ROE",
      "Values": "37.86%"
    },
    {
      "KPI": "ROCE",
      "Values": "22.95%"
    },
    {
      "KPI": "Debt/Equity",
      "Values": "2.16"
    },
    {
      "KPI": "RoNW",
      "Values": "31.83%"
    },
    {
      "KPI": "PAT Margin",
      "Values": "4.75"
    },
    {
      "KPI": "Price to Book Value",
      "Values": "8.57"
    }
  ],
  "EPS": [
    {
      "": "EPS (Rs)",
      "Pre IPO": "4.93",
      "Post IPO": "5.20"
    },
    {
      "": "P/E (x)",
      "Pre IPO": "27.36",
      "Post IPO": "25.94"
    }
  ],
  "objectives": [
    {
      "S.No.": "1",
      "Objects of the Issue": "Funding of expenses proposed to be incurred towards registration in Bolivia, South America",
      "Expected Amount(in Millions)": "12.90"
    },
    {
      "S.No.": "2",
      "Objects of the Issue": "Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises",
      "Expected Amount(in Millions)": "52.34"
    },
    {
      "S.No.": "3",
      "Objects of the Issue": "Advertising, marketing and brand building",
      "Expected Amount(in Millions)": "49.52"
    },
    {
      "S.No.": "4",
      "Objects of the Issue": "Investment in procuring hardware and software",
      "Expected Amount(in Millions)": "6.84"
    },
    {
      "S.No.": "5",
      "Objects of the Issue": "Funding of working capital requirements",
      "Expected Amount(in Millions)": "197.50"
    },
    {
      "S.No.": "6",
      "Objects of the Issue": "General corporate purposes",
      "Expected Amount(in Millions)": ""
    }
  ],
  "review": [
    {
      "Review By": "Brokers",
      "Subscribe": "0",
      "Neutral": "0",
      "Avoid": "0"
    },
    {
      "Review By": "Members",
      "Subscribe": "0",
      "Neutral": "0",
      "Avoid": "0"
    }
  ],
  "12": [
    [
      ""
    ]
  ],
  "prospectus_links": [
    {
      "title": "Astonea Labs IPO DRHP",
      "href": "https://www.bseindia.com/corporates/download/316805/DRHP%20ASTONEA%20LABS%20LTD_16.08.24_20240830124837.pdf",
      "text": "Astonea Labs IPODRHP"
    },
    {
      "title": "Astonea Labs IPO RHP",
      "href": "https://www.oneviewadvisors.com/upload/prospectus/RHP_astonealabs.pdf",
      "text": "Astonea Labs IPORHP"
    }
  ],
  "promoters": "Ashish Gulati is the promoter of the company.",
  "company_contact_details": {
    "company_name": "Astonea Labs Ltd",
    "address": "House No. 1358,, 1st Floor,, Sector-22B,, Phone, :, Email, :, Website, :",
    "phone": "+91  9888302323",
    "email": "cs@astonea.org",
    "website": "https://www.astonea.org/"
  },
  "ipo_registrar_details": {
    "name": "Kfin Technologies Limited",
    "phone": "04067162222",
    "email": "murali.m@kfintech.com",
    "website": "https://kosmic.kfintech.com/ipostatus/"
  },
  "about_company": {
    "description": "Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally. The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more. The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards. The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands \"Glow Up\" and \"Regero,\" plans to launch \"Avicel,\" and exports to countries like Iraq and Yemen. Produts and Offerings: As of August 16, 2024, the company had 217 employees on payroll. Competitive Strengths:",
    "competitive_strengths": []
  },
  "ipo_lead_managers": [
    {
      "name": "Oneview Corporate Advisors Pvt. Ltd.",
      "profile_link": "/report/ipo-lead-manager-review/112/94/",
      "title": "About Oneview Corporate Advisors Pvt. Ltd."
    }
  ],
  "listing_gain_percent": null
}